Mariko Sasaki

Targeting the Vulnerability of Glutathione Metabolism in ARID1A-Deficient Cancers

Hideaki Ogiwara, Kazuaki Takahashi, Mariko Sasaki et al. · Cancer Cell · 2019 · 296 citations · Full text

Medicine, Cancer Biology, Oncology +14

Targeting p300 Addiction in <i>CBP</i> -Deficient Cancers Causes Synthetic Lethality by Apoptotic Cell Death due to Abrogation of <i>MYC</i> Expression

Hideaki Ogiwara, Mariko Sasaki, Takafumi Mitachi et al. · Cancer Discovery · 2015 · 185 citations · Full text

Life Sciences, Cancer Biology, Oncology +17

Neutrophil extracellular trap components in fibrinoid necrosis of the kidney with myeloperoxidase-ANCA-associated vasculitis

M. Yoshida, Mariko Sasaki, Kota Sugisaki et al. · Clinical Kidney Journal · 2013 · 70 citations · Full text

Medicine, Immunology, Pathology +17

Therapeutic preferability of gemcitabine for ARID1A-deficient ovarian clear cell carcinoma

Takafumi Kuroda, Hideaki Ogiwara, Mariko Sasaki et al. · Gynecologic Oncology · 2019 · 36 citations · Full text

Medicine, Oncology, Pharmacology +12

Efficacy of glutathione inhibitors for the treatment of ARID1A-deficient diffuse-type gastric cancers

Mariko Sasaki, Fumiko Chiwaki, Takafumi Kuroda et al. · Biochemical and Biophysical Research Communications · 2019 · 25 citations

Medicine, Oncology, Pharmacology +14